Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jonathan Bean

Oral & Maxillofacial Surgery Columbia, SC Doctor of Dentistry

NPI 1326308628 CMS profile 2788070

9310 Two Notch Rd, Columbia, SC 29223

Open in the dashboard

General payments

$12,865

129 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jonathan Bean of Columbia, SC is reported in the CMS Open Payments database as having received $12,865 across 129 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $642 12
2024 General $7,847 53
2023 General $1,461 22
2022 General $2,029 21
2021 General $17 1
2020 General $186 11
2019 General $683 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jonathan Bean
  • Oral & Maxillofacial Surgery median
  • Middle half of Oral & Maxillofacial Surgery
  • National median

In program year 2025, general payments to Jonathan Bean were reported at $642. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.

Show as a table
Year Jonathan Bean Oral & Maxillofacial Surgery median Middle half National median
2019 $683 $178 $56–$584 $163
2020 $186 $106 $38–$316 $114
2021 $17 $165 $57–$511 $132
2022 $2,029 $173 $63–$494 $149
2023 $1,461 $184 $62–$521 $160
2024 $7,847 $197 $65–$603 $164
2025 $642 $184 $61–$541 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Straumann USA LLC $5,156 51 payments
  2. Zimvie Inc. $4,106 59 payments
  3. BioHorizons Implant Systems Inc. $3,337 15 payments
  4. Geistlich Pharma, North America, Inc. $188 1 payment
  5. Solventum Corporation $63 2 payments
  6. Nobel Biocare USA $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,973 109 payments
  2. Travel and Lodging $3,324 9 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,563 5 payments
  4. Consulting Fee $500 1 payment
  5. Education $469 3 payments
  6. Gift $36 2 payments
Products named General payments · program years 2019–2025
  1. BIOHORIZONS Implant Dentistry $3,298 14 payments
  2. BIOHORIZONS Implant Dentistry $3,298 14 payments
  3. BIOHORIZONS Implant Dentistry $3,298 14 payments
  4. BIOHORIZONS Implant Dentistry $3,298 14 payments
  5. BIOHORIZONS Implant Dentistry $3,298 14 payments
  6. Tapered Screw-Vent $1,721 15 payments
  7. 3i T3 $657 10 payments
  8. T3 $643 13 payments
  9. Diem2-RevitaliZe $519 9 payments
  10. OSSEOTITE NT $415 9 payments
  11. Other $615 17 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

605

Median for Oral & Maxillofacial Surgery: 284

Drug cost

$1,920

Median for Oral & Maxillofacial Surgery: $1,067

Branded share of claims

9.6%

Median for Oral & Maxillofacial Surgery: 17.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Chlorhexidine Gluconate Generic 260 $906
Amoxicillin Generic 152 $426
Ibuprofen Generic 99 $248
Clindamycin Hcl Generic 22 $136
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 18 $82
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 22 $71
Azithromycin Generic 14 $30
Ibu Ibuprofen Brand 18 $20

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 600 Part D prescribers listed as Oral & Maxillofacial Surgery; they describe a distribution and say nothing about conduct.

Records

129 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Oral & Maxillofacial Surgery in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record